Fundraising Fox
/Investor DB
Sign in

Wu Capital — 2017 Investments

1 investments dated 2017 · listed companies and verified rows first · show all

Semma Therapeuticssemma-tx.comNov 2017acquired by Vertex Pharmaceuticals · Sep 2019 · $950M

Cambridge, MA biotech developing stem cell-derived islet therapy plus an immune-protective device for type 1 diabetes; acquired by Vertex for $950M.

BiotechCambridge, US

Robert Millman(Executive Officer, Director)

BoardTodd Foley(Executive Officer, Director)inMitch Finer(Director)Stephen Knight(Director)inJim Scopa(Director)William Sahlman(Director)

Co-investorsARCH Venture PartnersF-Prime CapitalJDRF T1D FundORI CapitalSlater Technology Fund6 Dimensions Capital+4 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.